ANADYS PHARMACEUTICALS
Anadys Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics for the treatment of chronic hepatitis C viral infections. The company focuses on the development of ANA598, a direct-acting antiviral (DAA) for the treatment of hepatitis C. It also focuses to resume the clinical development of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7 or TLR7. Anadys Pharmaceuticals was founded in 1992 and is headquartered in San Diego, California. As of November 22, 2011, Anadys Pharmaceuticals operates as a subsidiary of Hoffmann-La Roche Inc.
ANADYS PHARMACEUTICALS
Industry:
Biotechnology Health Care
Founded:
1992-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.anadyspharma.com
Total Employee:
1+
Status:
Active
Contact:
(858)530-3600
Total Funding:
71.3 M USD
Similar Organizations
Nereus Pharmaceuticals
Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.
Current Advisors List
Founder
Investors List
Venrock
Venrock investment in Private Equity Round - Anadys Pharmaceuticals
Coastview Capital
Coastview Capital investment in Private Equity Round - Anadys Pharmaceuticals
Lotus BioScience Ventures
Lotus BioScience Ventures investment in Private Equity Round - Anadys Pharmaceuticals
HBM Partners
HBM Partners investment in Private Equity Round - Anadys Pharmaceuticals
Venrock
Venrock investment in Seed Round - Anadys Pharmaceuticals
